Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder

To date, there are no biomarkers for major depressive disorder (MDD) treatment response in clinical use. Such biomarkers could allow for individualized treatment selection, reducing time spent on ineffective treatments and the burden of MDD. In search of such a biomarker, multisite pretreatment and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuropsychopharmacology
Main Authors: Bartlett, Elizabeth A., DeLorenzo, Christine, Sharma, Priya, Yang, Jie, Zhang, Mengru, Petkova, Eva, Weissman, Myrna, McGrath, Patrick J., Fava, Maurizio, Ogden, R. Todd, Kurian, Benji T., Malchow, Ashley, Cooper, Crystal M., Trombello, Joseph M., McInnis, Melvin, Adams, Phillip, Oquendo, Maria A., Pizzagalli, Diego A., Trivedi, Madhukar, Parsey, Ramin V.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6135779/
https://ncbi.nlm.nih.gov/pubmed/29955151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-018-0122-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados